Neuronetics (STIM) EBITDA (2017 - 2026)
Neuronetics' (STIM) quarterly EBITDA came in at -$9.0 million in Q1 2026, up 18.33% year-on-year from -$7.6 million in Q1 2025, and down 78.37% on a QoQ basis from -$5.0 million in Q4 2025.
Neuronetics (STIM) EBITDA (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of EBITDA data on file, last reported at -$9.0 million in Q1 2026.
- On a quarterly basis, EBITDA rose 18.33% year-over-year to -$9.0 million in Q1 2026; TTM through Mar 2026 was -$29.4 million, a 24.03% increase from a year earlier, with the FY2025 full-year figure at -$31.4 million, up 9.05% from the prior year.
- EBITDA for Q1 2026 stood at -$9.0 million, down from -$5.0 million in the prior quarter.
- Over the last five years, EBITDA for STIM reached as high as -$4.4 million in Q4 2023 and fell as low as -$11.5 million in Q4 2024.
- Historically, EBITDA has averaged -$8.3 million across 5 years, with a median of -$8.1 million in 2025.
- Across the five-year window, EBITDA sank 159.14% in 2024 and soared 56.04% in 2025, its largest moves.
- Year by year, EBITDA stood at -$7.7 million in 2022, then jumped by 42.71% to -$4.4 million in 2023, then tumbled by 159.14% to -$11.5 million in 2024, then surged by 56.04% to -$5.0 million in 2025, then slumped by 78.37% to -$9.0 million in 2026.
- Per Business Quant data, the three most recent EBITDA figures were -$9.0 million in Q1 2026, -$5.0 million in Q4 2025, and -$7.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | -9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.00 Mn |
| Dec 31, 2025 | -5.04 Mn |
| Sep 30, 2025 | -7.32 Mn |
| Jun 30, 2025 | -8.06 Mn |
| Mar 31, 2025 | -11.01 Mn |
| Dec 31, 2024 | -11.47 Mn |
| Sep 30, 2024 | -7.73 Mn |
| Jun 30, 2024 | -8.51 Mn |
| Mar 31, 2024 | -6.86 Mn |
| Dec 31, 2023 | -4.43 Mn |
| Sep 30, 2023 | -8.87 Mn |
| Jun 30, 2023 | -7.35 Mn |
| Mar 31, 2023 | -9.91 Mn |
| Dec 31, 2022 | -7.73 Mn |
| Sep 30, 2022 | -7.45 Mn |
| Jun 30, 2022 | -9.80 Mn |
| Mar 31, 2022 | -10.14 Mn |
| Dec 31, 2021 | -6.91 Mn |
| Sep 30, 2021 | -7.18 Mn |
| Jun 30, 2021 | -6.56 Mn |